Lourdes Sainero Alcolado

Artiklar

Article: SCIENTIFIC REPORTS. 2023;13(1):1273

Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition.

Graziani V; Garcia AR; Alcolado LS; Le Guennec A; Henriksson MA; Conte MR
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2022;41(1):226

Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.

Sainero-Alcolado L; Mushtaq M; Liaño-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Pérez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
Article: CHEMPHOTOCHEM. 2021;5(7):632-643

Photophysical Characteristics of Polarity-Sensitive and Lipid Droplet-Specific Phenylbenzothiadiazoles

Colas K; Doloczki S; Kesidou A; Sainero-Alcolado L; Rodriguez-Garcia A; Arsenian-Henriksson M; Dyrager C
Article: ISCIENCE. 2021;24(2):102128

Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma.

Ruiz-Pérez MV; Sainero-Alcolado L; Oliynyk G; Matuschek I; Balboni N; Ubhayasekera SJKA; Snaebjornsson MT; Makowski K; Aaltonen K; Bexell D; Serra D; Nilsson R; Bergquist J; Schulze A; Arsenian-Henriksson M
Article: ISCIENCE. 2019;21:188-204

MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma.

Oliynyk G; Ruiz-Pérez MV; Sainero-Alcolado L; Dzieran J; Zirath H; Gallart-Ayala H; Wheelock CE; Johansson HJ; Nilsson R; Lehtiö J; Arsenian-Henriksson M

Thesis / dissertation: 2022

Impact of targeting MYC in metabolic reprogramming and differentiation of cancer

Sainero Alcolado, Lourdes
Review: CELL DEATH AND DIFFERENTIATION. 2022;29(7):1304-1317

Targeting mitochondrial metabolism for precision medicine in cancer.

Sainero-Alcolado L; Liaño-Pons J; Ruiz-Pérez MV; Arsenian-Henriksson M

Postdoktor, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2023-2025

Medicine Doktorsexamen, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2023